{"filing":{"accession_number":"0000019584-26-000018","cik":"0000019584","ticker":"CHE","company_name":"CHEMED CORP","form":"8-K","filing_date":"2026-07-28","report_date":"2026-07-28","primary_document":"che-20260728x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/19584/000001958426000018/che-20260728x8k.htm"},"events":[{"id":21153,"run_id":19067,"accession_number":"0000019584-26-000018","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"summary":"This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) issued on July 28, 2026. The press release discloses consolidated financial results including revenue ($673.3M, up 8.8%), GAAP diluted EPS ($5.13, up 43.7%), and adjusted diluted EPS ($6.06, up 41.9%), along with segment-level performance metrics for VITAS and Roto-Rooter, updated full-year guidance, and detailed financial statements. This is a material disclosure affecting investor assessment of the registrant's financial performance and prospects.","company_name":"CHEMED CORP","ticker":"CHE","filing_date":"2026-07-28","form":"8-K","submitted_at":null,"items":[{"id":20713,"accession_number":"0000019584-26-000018","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) issued on July 28, 2026. The press release discloses consolidated financial results including revenue ($673.3M, up 8.8%), GAAP diluted EPS ($5.13, up 43.7%), and adjusted diluted EPS ($6.06, up 41.9%), along with segment-level performance metrics for VITAS and Roto-Rooter, updated full-year guidance, and detailed financial statements. This is a material disclosure affecting investor assessment of the registrant's financial performance and prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:32:23.868618+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20713,"accession_number":"0000019584-26-000018","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) issued on July 28, 2026. The press release discloses consolidated financial results including revenue ($673.3M, up 8.8%), GAAP diluted EPS ($5.13, up 43.7%), and adjusted diluted EPS ($6.06, up 41.9%), along with segment-level performance metrics for VITAS and Roto-Rooter, updated full-year guidance, and detailed financial statements. This is a material disclosure affecting investor assessment of the registrant's financial performance and prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:32:23.868618+00:00","company_name":"CHEMED CORP","ticker":"CHE","filing_date":"2026-07-28"}]}